glp-1 side Drug Effects May Be Tackled with More Mechanistic Studies GLP-1 Medications | Daniel Stark

The scientific landscape is dynamic, and best practices evolve

Wadden TA, Bailey TS, Billings LK et al (2021) Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial

Pharma Industry 2 min read WHO adds GLP-1 drugs for diabetes, others to essential medicines list The drugs were initially developed for diabetes but have also become hugely popular weight-loss drugs, under different brand names

Positioning GLP 1 RAs as Lifestyle Optimization Tools GLP-1 RA drugs were initially developed for individuals with obesity and type 2 diabetes, but their reach has extended far beyond this population

They can discuss the risks and benefits of using direct-to-consumer telehealth services that offer compounded drugs, which may be cheaper but lack FDA oversight